What determines severity among patients with painful functional bowel disorders?
- PMID: 10763947
- DOI: 10.1111/j.1572-0241.2000.01936.x
What determines severity among patients with painful functional bowel disorders?
Abstract
Objective: For patients with painful functional bowel disorders (FBD), physicians frequently make diagnostic and treatment decisions based on the severity of the pain reported; patients with severe painful complaints may receive extensive diagnostic tests and treatments. Therefore, it would be important to determine what clinical factors contribute to the judgment of severity among patients with FBD. The aim of this study was to identify the psychosocial, behavioral, and physiological (visceral sensitivity) factors that predicted severity in patients with moderate to severe FBD.
Methods: Two hundred eleven female patients with moderate or severe FBD, as determined by the Functional Bowel Disorder Severity Index, entered a multicenter treatment trial at the University of North Carolina and the University of Toronto. Patients filled out diary cards and were given questionnaires and physiological testing (rectal sensitivity using barostat). Analysis of covariance and logistic regression adjusting for demographic factors were performed to determine which factors distinguished patients at study entry with moderate from those with severe FBD.
Results: Patients with severe FBD were characterized by greater depression and psychological distress, poorer physical functioning and health-related quality of life, more maladaptive coping strategies, and greater health care utilization. There was a trend for patients with severe FBD to have lower rectal sensation thresholds. Regression analysis indicated that severity was best predicted by behavioral features: poorer daily physical function, difficulties related to eating, more phone calls to the physician, and more days in bed for GI symptoms.
Conclusions: We conclude that patient illness behaviors are best correlated with severity in FBD. The use of psychopharmacological agents (e.g., antidepressants) and psychological treatments to treat psychiatric comorbidity and to improve behavioral coping styles is recommended. Training to help medical physicians identify and respond to psychosocial and behavioral features of these conditions is likely to improve patient satisfaction with their care and the clinical outcome.
Comment in
-
Symptom expression in pain-predominant functional bowel syndrome: is visceral hyperalgesia the whole truth?Am J Gastroenterol. 2000 Apr;95(4):862-3. doi: 10.1111/j.1572-0241.2000.01973.x. Am J Gastroenterol. 2000. PMID: 10763924 No abstract available.
Similar articles
-
Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment.Am J Gastroenterol. 2007 Jul;102(7):1442-53. doi: 10.1111/j.1572-0241.2007.01283.x. Epub 2007 May 17. Am J Gastroenterol. 2007. PMID: 17509027 Clinical Trial.
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
Sleep disturbances in clinic patients with functional bowel disorders.Am J Gastroenterol. 2000 May;95(5):1195-2000. doi: 10.1111/j.1572-0241.2000.02009.x. Am J Gastroenterol. 2000. PMID: 10811327
-
Review article: epidemiology and quality of life in functional gastrointestinal disorders.Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:31-9. doi: 10.1111/j.1365-2036.2004.02183.x. Aliment Pharmacol Ther. 2004. PMID: 15521853 Review.
-
Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?Am J Med. 1999 Nov 8;107(5A):41S-50S. doi: 10.1016/s0002-9343(99)00081-9. Am J Med. 1999. PMID: 10588172 Review.
Cited by
-
Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?Therap Adv Gastroenterol. 2009 Jul;2(4):5-8. doi: 10.1177/1756283X09337569. Therap Adv Gastroenterol. 2009. PMID: 21180549 Free PMC article.
-
On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.Int J Clin Pract. 2014 Feb;68(2):245-54. doi: 10.1111/ijcp.12333. Epub 2013 Oct 21. Int J Clin Pract. 2014. PMID: 24147869 Free PMC article. Clinical Trial.
-
Not all side effects associated with tricyclic antidepressant therapy are true side effects.Clin Gastroenterol Hepatol. 2009 Apr;7(4):446-51. doi: 10.1016/j.cgh.2008.11.014. Epub 2008 Nov 21. Clin Gastroenterol Hepatol. 2009. PMID: 19167522 Free PMC article. Clinical Trial.
-
Brain-Gut Interactions in IBS.Front Pharmacol. 2012 Jul 5;3:127. doi: 10.3389/fphar.2012.00127. eCollection 2012. Front Pharmacol. 2012. PMID: 22783191 Free PMC article.
-
Constructive thinking, rational intelligence and irritable bowel syndrome.World J Gastroenterol. 2009 Jul 7;15(25):3106-13. doi: 10.3748/wjg.15.3106. World J Gastroenterol. 2009. PMID: 19575489 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical